Pharmather Holdings Ltd
CNSX:PHRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Wanderport Corp
OTC:WDRP
|
US |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
P
|
Pharmather Holdings Ltd
CNSX:PHRM
|
6.4m CAD |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
901.8B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD |
Loading...
|
Market Distribution
Other Profitability Ratios
Pharmather Holdings Ltd
Glance View
PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company, which engages in the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative, and pain disorders. The company is headquartered in Toronto, British Columbia. The company went IPO on 2020-10-09. The firm is focused on the research, development and commercialization uses, formulations and delivery methods of psychedelics to treat mental illness, neurological and pain disorders. The firm's product pipeline targets the use of ketamine to treat Parkinson’s disease, depression, amyotrophic lateral sclerosis (Lou Gehrig’s disease) and pain. The firm is also focused on developing a microneedle patch to deliver ketamine and other psychedelics, such as psilocybin, N, N-Dimethyltryptamine (DMT), Lysergic acid diethylamide (LSD) and 3,4-Methylenedioxymethamphetamine (MDMA).
